Literatur
Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, Weidner W, Loeb S (2016) Complications after systematic, random, and image-giuded prostate biopsy. Eur Urol. doi:10.1016/j.eururo.2016.08.004
Wagenlehner FME, van Ostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE (2013) Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPUI) 2010 and 2011, a prospective multinational Multicentre prostate biopsy study. Eur Urol 63:521–527
Robert Koch Institut: Epidemiologisches Bulletin 27.Juni 2016/Nr. 25 – Bericht des Nationalen Referenzzentrums (NRZ) für gramnegative Krankenhauserreger – Zeitraum 1. Januar 2015 bis 31. Dezember 2015
Cai T, Gallelli L, Cocci A, Tiscione D, Verze P, Lanciotti M, Vanacore D, Rizzo M, Gacci M, Saleh O, Malossini G, Liguori G, Trombetta C, Rocco D, Palmieri A, Bartoletti R, Carini M, Wagenlehner FME, Naber K, Mirone V, Bjerklund-Johanson TE (2016) Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World J Urol. doi:10.1007/s00345-016-1867-6
Agbugui JO, Obarisiagon EO, Osaigbovo EO, Osime CO, Akumbar PN (2014) Antibiotic prophylaxis for transrectal prostate biopsy: a comparison of one-day and five-day regimen. Niger Postgrad Med J 21:213–217
Bateni ZH, Hossein S, Salimi H, Safari H, Tabatabei M, Saedi D (2014) Single-dose versus multi-dose ciprofloxacin plus Metronidazole prophylaxis in transrectal ultrasound-guided biopsy of the prostate: a randomized controlled trial. Acta Med Iran 52:664–670
AbuGosh Z, Margolik J, Goldenberg SL, Teylor SA, Afshar K, Bell R, Lange D, Bowie WR, Roscoe D, Machan L, Black PC (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189:1326–1331
Chan ES, Lo KL, Ng CF, Hou SM, Yip SK (2012) Randomized controlled trial of antibiotic prophylaxis regimen for transrectal ultrasound-guided prostate biopsy. Chin Med J 125(14):2432–2435
Sen V, Ayodogdu O, Bozkurt IH, Yonguc T, Sen P, Polat S, Degirmenci T, Bolat D (2015) The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study. Can Urol Assoc J 9:863–867
Qiao LD, Chen S, Wang XF, Yang WM, Niu YJ, Kong CZ, Tang W, Gao XF, Shi BK, Na YQ, Zhang XD, Wang JY, Zhang Y, Chen Z (2016) A multi-center, controlled, randomized, open-label clinical study of levofloxacin for preventing infection during perioperative period of ultrasound-guided transrectal prostate biopsy. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-016-2742-5
Miyazaki Y, Akamatsu S, Kanamaru S, Kamiyama Y, Sengiku A, Iguchi R, Sano T, Takahashi A, Ito M, Takenawa J, Ito N, Ogura K (2016) A prospective randomized trial comparing a combined regimen of amakin and levofloxacin to levofloxacin alone as prophylaxis in transrectal prostate needle bopsy. Urol Oncol 13:2533–2540
Samarinas M, Dimitropoulos K, Zachos I, Gravas S, Karatzas A, Tzortzis V (2016) A single dose of meropenem is superior to ciprofloxacin in preventing infections after trabsrectal ultrasound-guided prostate biopsies in the era of quinolone resistance. World J Urol. doi:10.1007/s00345-016-180-z
Schneidewind L, Kranz J, Boehm K, Spachmann P, Siegel F, Huck N, Fritsche HM (2016) Antibiotic stewardship (ABS). Definition, contents, necessity and practice on examples of current clinical urological controversies. Urologe A 55:489–493
Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schröder FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a european randomized trial. Eur Urol 61:1110–1114
Wagenlehner FME (2014) Editorial comment from Dr. Wagenlehner to hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England. Int J Urol. doi:10.1111/iju.12646
Cussans A, Somani BK, Basarab A, Dudderidge TJ (2016) The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int 117:725–731
Liss MA, Nakamura KK, Mauleners R, Kolla SB, Dash A, Peterson EM (2013) Screening rectal culture to identify fluorchinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate? Urology 82:67–73
van Besien J, Uvin P, van den Abeele AM, Merckx L (2016) Prevalence, risk factors, and clinical relevance of fluorchinolone-resistant organisms in rectal cultures: should we target antibiotic prophylaxis prior to prostate biopsy? Adv Urol. doi:10.1155/2016/5392107
Tsivian M, Abern MR, Qi P, Polascik TJ (2013) Short-term functional outcome and complications associated with transperineal template prostate mapping biopsy. Urology 82:166–170
Yang L, Gao L, Chen Y, Tang Z, Liu L, Han P, Zeng H, Li X, Wei Q (2015) Prophylactic antibiotics in prostate biopsy: a meta-analysis based on randomized controlled trials. Surg Infect 16:733–747
Cai T, Verze P, Brugnolli A, Tiscione D, Lucianni LG, Eccher C, Lanzafane P, Malossini G, Wagenlehner FME, Mirone V, Bjerklund-Johansen TE, Pickard R, Bartoletti R (2016) Adherence to European association of urology guidelines on prophylactic antibiotics: an important step in antimicrobial stewardship. Eur Urol 69:276–283
Iarikov D, Wassel R, Farley J, Nambiar S (2015) Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA adverse event reporting system database. Infect Dis Ther 4:433–458
Deutsche Gesellschaft für Infektiologie (2013) S3-Leitlinie: Strategien zur Sicherung rationaler Antibiotika-AnwendungimKrankenhaus. http://www.awmf.org/leitlinien/detail/ll/092-001.html. Zugegriffen: 9. Nov. 2016
Danksagung
UroEvidence dankt Ingrid Töws und Katharina Kunzweiler (beide Cochrane Deutschland) für die Durchsicht und Kommentare zu dieser Übersetzung.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
L. Schneidewind gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Schneidewind, L. Antibiotische Prophylaxe für transrektale Prostatastanzbiopsien. Urologe 56, 60–64 (2017). https://doi.org/10.1007/s00120-016-0283-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-016-0283-2